BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31919459)

  • 1. MicroRNA profiles in serum samples from Acute-On-Chronic Liver Failure patients and miR-25-3p as a potential biomarker for survival prediction.
    Cisilotto J; do Amaral AE; Rosolen D; Rode MP; Silva AH; Winter E; da Silva TE; Fischer J; Matiollo C; Rateke ECM; Narciso-Schiavon JL; Schiavon LL; Creczynski-Pasa TB
    Sci Rep; 2020 Jan; 10(1):100. PubMed ID: 31919459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
    Yan H; Jin S; Liang L; Du J; Aithal GP; Li L
    Scand J Gastroenterol; 2020 May; 55(5):606-614. PubMed ID: 32476510
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure.
    Wen Y; Peng SF; Fu L; Fu XY; Wu DX; Liu BJ; Tan DM; Ouyang Y
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):126-132. PubMed ID: 29602672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis.
    Silva PE; Fayad L; Lazzarotto C; Ronsoni MF; Bazzo ML; Colombo BS; Dantas-Correa EB; Narciso-Schiavon JL; Schiavon LL
    Liver Int; 2015 May; 35(5):1516-23. PubMed ID: 24840673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
    Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ;
    Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality.
    Mücke MM; Rumyantseva T; Mücke VT; Schwarzkopf K; Joshi S; Kempf VAJ; Welsch C; Zeuzem S; Lange CM
    Liver Int; 2018 Apr; 38(4):645-653. PubMed ID: 28853199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.
    Dhiman RK; Agrawal S; Gupta T; Duseja A; Chawla Y
    World J Gastroenterol; 2014 Oct; 20(40):14934-41. PubMed ID: 25356054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure.
    Mani I; Alexopoulou A; Vasilieva L; Hadziyannis E; Agiasotelli D; Bei M; Alexopoulos T; Dourakis SP
    Liver Int; 2019 Feb; 39(2):299-306. PubMed ID: 30261128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.
    Bernsmeier C; Cavazza A; Fatourou EM; Theocharidou E; Akintimehin A; Baumgartner B; Dhar A; Auzinger G; Thursz M; Bernal W; Wendon JA; Karvellas CJ; Antoniades CG; McPhail MJW
    Aliment Pharmacol Ther; 2020 Sep; 52(5):855-865. PubMed ID: 32683724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcomes of acute-on-chronic liver failure patients with or without cirrhosis using two criteria.
    Dong X; He J; Chen W; Su R; Xu Y; Sheng X; Li L; Cao H
    Sci Rep; 2020 May; 10(1):8577. PubMed ID: 32444697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis.
    Matiollo C; Rateke ECM; de Oliveira KG; Turnes BL; da Silva TE; Maccali C; Latini AS; Narciso-Schiavon JL; Schiavon LL
    Dig Liver Dis; 2020 Jul; 52(7):753-760. PubMed ID: 32434738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
    Trebicka J; Amoros A; Pitarch C; Titos E; Alcaraz-Quiles J; Schierwagen R; Deulofeu C; Fernandez-Gomez J; Piano S; Caraceni P; Oettl K; Sola E; Laleman W; McNaughtan J; Mookerjee RP; Coenraad MJ; Welzel T; Steib C; Garcia R; Gustot T; Rodriguez Gandia MA; Bañares R; Albillos A; Zeuzem S; Vargas V; Saliba F; Nevens F; Alessandria C; de Gottardi A; Zoller H; Ginès P; Sauerbruch T; Gerbes A; Stauber RE; Bernardi M; Angeli P; Pavesi M; Moreau R; Clària J; Jalan R; Arroyo V
    Front Immunol; 2019; 10():476. PubMed ID: 30941129
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure.
    Tao YC; Wang ML; Wang M; Ma YJ; Bai L; Feng P; Chen EQ; Tang H
    Dig Liver Dis; 2019 Mar; 51(3):412-418. PubMed ID: 30274791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the prognostic models in acute-on-chronic liver failure precipitated by hepatic and extrahepatic insults.
    Maipang K; Potranun P; Chainuvati S; Nimanong S; Chotiyaputta W; Tanwandee T; Charatcharoenwitthaya P
    PLoS One; 2019; 14(7):e0219516. PubMed ID: 31291342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.
    Ruiz-Margáin A; Pohlmann A; Ryan P; Schierwagen R; Chi-Cervera LA; Jansen C; Mendez-Guerrero O; Flores-García NC; Lehmann J; Torre A; Macías-Rodríguez RU; Trebicka J
    Liver Transpl; 2018 May; 24(5):595-605. PubMed ID: 29476704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
    Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
    Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure.
    Song DS; Kim TY; Kim DJ; Kim HY; Sinn DH; Yoon EL; Kim CW; Jung YK; Suk KT; Lee SS; Lee CH; Kim TH; Choe WH; Yim HJ; Kim SE; Baik SK; Jang JY; Kim HS; Kim SG; Yang JM; Sohn JH; Choi EH; Cho HC; Jeong SW; Kim MY;
    J Gastroenterol Hepatol; 2018 Apr; 33(4):900-909. PubMed ID: 28921629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
    Li H; Chen LY; Zhang NN; Li ST; Zeng B; Pavesi M; Amorós À; Mookerjee RP; Xia Q; Xue F; Ma X; Hua J; Sheng L; Qiu DK; Xie Q; Foster GR; Dusheiko G; Moreau R; Gines P; Arroyo V; Jalan R
    Sci Rep; 2016 May; 6():25487. PubMed ID: 27146801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.
    Jalan R; Saliba F; Pavesi M; Amoros A; Moreau R; Ginès P; Levesque E; Durand F; Angeli P; Caraceni P; Hopf C; Alessandria C; Rodriguez E; Solis-Muñoz P; Laleman W; Trebicka J; Zeuzem S; Gustot T; Mookerjee R; Elkrief L; Soriano G; Cordoba J; Morando F; Gerbes A; Agarwal B; Samuel D; Bernardi M; Arroyo V;
    J Hepatol; 2014 Nov; 61(5):1038-47. PubMed ID: 24950482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.